Shenda Orrego

5PUBLICATIONS
10CO-AUTHORS
Medical mycologyPredictive and prognostic markersMedical microbiology not elsewhere classifiedMedical infection agents (incl. prions)Medical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 28, 2021
Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone.

Nigel P Murray, Ricardo Villalon, Shenda Orrego

|Nov 10, 2020
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery alone.

Nigel P Murray, Ricardo Villalon, Shenda Orrego

|Jul 25, 2020
The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy.

Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes

|May 14, 2020
The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancer.

Nigel P Murray, Eduardo Reyes, Anibal Salazar

|Nov 25, 2019
Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells.

Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes

Pageof 1

Frequent Collaborators

5 joint publications

Nigel P Murray

4 joint publications

Eghon Guzman

3 joint publications

Eduardo Reyes

2 joint publications

Marco Antonio Lopez